New therapy turns cancer cells into fat to stop it from spreading

Researchers at the University of Basel in Switzerland have hijacked cancer's cellular plasticity to turn the disease against itself.

  • In 2018, an estimated 627,000 women died from breast cancer worldwide.
  • Researchers recently discovered a drug combination that turned cancer cells into fat cells, preventing its proliferation.
  • The drug therapy could be used to halt metastasis, the leading cause of death from cancer.

It may be a family member, a friend, a coworker, or even yourself, but chances are breast cancer will invade your life at some point. According to the Center for Disease Control and Prevention, 242,476 new cases of female breast cancer were reported in 2015 alone. The disease took the lives of 41,523 women that same year. This makes breast cancer the most commonly diagnosed cancer, and the second leading cause of cancer deaths among American women.

Worldwide, cancers represent the second leading cause of death, surpassed only by heart disease. Yet despite these disheartening numbers, we are making progress in developing effective treatments against this deadly affliction.

Scientists may have given us another tool to further this progress. They've developed a new drug therapy that prevents malignant cancer growth. How? By turning cancer cells into fat.

The good kind of fat

Low magnification micrograph of a metastatic tumor [left side] in the ovary. This tumor metastasized from a tumor in the woman's breast. Photo credit: Wikimedia Commons

Metastasis is the leading cause of death from cancer, occurring when cancer cells separate from the original tumor to proliferate elsewhere. These new cancer cells travel through the bloodstream or lymphatic system. Since these bodily systems are thoroughly connected, cancer can spread to a variety of locations. Breast cancer, for example, "tends to spread to the bones, liver, lungs, chest wall, and brain."

Cancer cell plasticity — an ability that allows cancer cells to shift physiological characteristics dramatically — fosters metastasis and is responsible for cancer's resistance to treatments. To combat its resistance, researchers at the University of Basel in Switzerland decided to turn cancer's cellular plasticity against itself. They used Rosiglitazone, an anti-diabetic drug, along with MEK inhibitors in mice implanted with breast cancer cells. Their aim was to alter the cancer cells.

The drug combination hijacked the breast cancer cells during epithelial-mesenchymal transition (EMT), a process by which the cells undergo biochemical changes. EMT plays a role in many bodily functions, such as tissue repair. In unaltered cancer cells, EMT allows them to migrate away from the original tumor while maintaining their oncogenic properties.

But in cancer cells assaulted by the new drug therapy, EMT changes them into adipocytes, or fat cells. Like normal fat cells, these former breast cancer cells were both functional and post-mitotic, meaning they could no longer divide and proliferate.

While the therapy did not alter the original tumor, it did prevent new cancer cells from dividing and spreading elsewhere in the body. This repressed metastasis in the researcher's preclinical trials.

The researchers published their findings on January 14 in the journal Cancer Cell.

"In future, this innovative therapeutic approach could be used in combination with conventional chemotherapy to suppress both primary tumor growth and the formation of deadly metastases," senior study author Gerhard Christofori told Medical News Today.

Since the research used FDA-approved drugs to study the treatment's effects, the study notes, "a clinical translation may be possible."

Will we win the battle against cancer?

Members of Lebanon's Ladies of Harley hold placards as take part in an event organised by Pink Steps Lebanon to raise awareness about breast cancer on October 28, 2018. Photo credit: MAHMOUD ZAYYAT / AFP / Getty Images

This article opened with some fearful figures about cancer and its effect on people worldwide. But there's reason to hope.

While the total number of new cancer cases and deaths continues to increase, the rates of cancer diagnoses and deaths decline each year — as absolute figures don't account for rises in life expectancy, population growth, or aging populations. We've made great strides in understanding the disease and its various genetic and environmental origins. And events like Breast Cancer Awareness Month continue to educate the populace about the preventative measures available to them.

Thanks to scientists like those at the University of Basel in Switzerland, we may have more reasons to be hopeful very soon.

Should you defend the free speech rights of neo-Nazis?

Former president of the ACLU Nadine Strossen discusses whether our society should always defend free speech rights, even for groups who would oppose such rights.

Sponsored by Charles Koch Foundation
  • Former ACLU president Nadine Strossen understands that protecting free speech rights isn't always a straightforward proposition.
  • In this video, Strossen describes the reasoning behind why the ACLU defended the free speech rights of neo-Nazis in Skokie, Illinois, 1977.
  • The opinions expressed in this video do not necessarily reflect the views of the Charles Koch Foundation, which encourages the expression of diverse viewpoints within a culture of civil discourse and mutual respect.
Keep reading Show less

Belly fat: Gut bacteria checks could lead to personalized diets

The reason one diet does not suit all may be found in our guts.

Media for Medical / Getty Images
Surprising Science
Keep reading Show less

NASA releases stunning image of ISS crossing in front of the sun

Strangely, the sun showed no sunspots at the time the photo was taken.

Image source: Rainee Colacurcio
Surprising Science
  • The photo shows the International Space Station as it orbits the Earth, as it does every 90 minutes.
  • The photo is remarkable because it offers a glimpse of the star at a time when there were no sunspots.
  • In November, astronauts aboard the ISS plan to grow Española chili pepper plants.
Keep reading Show less

Learn to design the life you love

Part 1: Deconstruction

Photo by Vadim Sherbakov
Big Think Edge
  • Deconstruction is exactly what it sounds like—a method for breaking your life down into its simplest component parts.
  • Ayse Birsel argues that deconstruction is like taking a camera apart: you can't possibly put it back together in the same way.
  • Be sure to check out Design the Life You Love, Part 2: Reconstruction to learn how to put the pieces of your life back together in a realistic way. Sign up for Big Think Edge to see exclusive more content!